Creutzfeldt-Jakob Disease

Pathogenic form of human prion proteins can be removed

Published in Blood Weekly, December 26th, 2002

Bayer Biological Products scientists have demonstrated the ability of current purification processes to remove pathogenic forms of human prion proteins, including the prion protein associated with variant Creutzfeldt-Jakob disease (vCJD), during simulations of the process for manufacturing plasma proteins.

Collaborating with the New York State Institute for Basic Research in Developmental Disabilities and the National Institute of Neurological Disorders and Stroke, Bayer BP scientists measured the removal of pathogenic prion proteins purposely added under experimental conditions to human plasma samples undergoing purification processes that simulate those used in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-12-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry